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Not Necessarily at OddsValentin Fuster, MD, PHDA few months ago, we learned that the Journalof the American College of Cardiology hadachieved the number 1 status for Impact
Factor among the 125 cardiovascular journals in the
world. This was a tremendous honor for the Journal,
and one for which I must applaud the work of my pre-
decessor, Dr. Tony DeMaria. This distinction has led
me to intensely consider the meaning behind Impact
Factor, which is published annually by Thomson Reu-
ters and is based on the approximate average number
of citations for a given journal.
Since its inception in 1955, much has been writ-
ten about the concept of Impact Factor. In fact,
Dr. C. Hoffel adeptly wrote a letter about the quandary
in 1998 in Allergy:
Impact Factor is not a perfect tool to measure
the quality of articles but there is nothing bet-
ter and it has the advantage of already being in
existence and is, therefore, a good technique
for scientiﬁc evaluation. Experience has shown
that in each specialty the best journals are
those in which it is most difﬁcult to have an
article accepted, and these are the journals that
have a high Impact Factor. Most of these jour-
nals existed long before the impact factor was
devised. The use of Impact Factor as a measure
of quality is widespread because it ﬁts well
with the opinion we have in each ﬁeld of the
best journals in our specialty (1).
Even one of the cocreators of the Impact Factor,
Dr. Eugene Garﬁeld, spoke about its imperfections at
the Impact Factor Fifth International Congress on
Peer Review in Biomedical Publication in Chicago in. Wiener Cardiovascular Institute, Icahn
inai, New York, New York.2005 (2). However, as Garﬁeld pointed out, it seems
highly improbable that a new evaluation system
wherein individual papers are read and evaluated
for quality will be implemented. Thus, this system—
however complicated or imperfect—currently exists
as the main metric by which to scrutinize the impor-
tance of scientiﬁc and medical journals.
The annual announcement of Impact Factor fosters
incredible competition among the top-ranked jour-
nals. And, while attending the European Society of
Cardiology Congress in Barcelona in August, count-
less people questioned me about the pressures
of maintaining this status. Each time I received this
question, I was reminded how reviewers often advo-
cate for original studies to be accepted, because they
will be highly cited and could affect the Journal’s
Impact Factor. Personally, when faced with such
claims, I always ask, “Is this study going to impact
practice?” This is where the real value lies-in pub-
lishing papers that can help inform the clinician with
his or her patients. Although I acknowledge that some
of these papers could be highly cited, I usually
recommend that we not accept the manuscript,
because “citability” or the Impact Factor is not
reason enough to publish a paper. If we are only
looking to further the reputation of our journals
without bringing true value to our readers, then we
are doing our readers a disservice—when our only
goal should be to serve them.
Another important aspect related to Impact Factor
is that the top 3 cardiovascular journals are separated
by <0.65 points (Table 1). If you consider the minus-
cule differences separating us and how quickly these
numbers can ﬂuctuate, it suddenly seems superﬂuous
that people try to predict each year’s ranking with
such fervor. More importantly, focusing on Impact
Factor could distract from the more important goal of
serving our readers with the highest-quality papers
TABLE 1 2013 Impact Factor Rankings
Journal Impact Factor
Journal of the American College of Cardiology 15.343
Circulation 14.948
European Heart Journal 14.723
Data from Thomson Reuters (4).
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1754that will help them improve patient treatment—
starting with fellows to the most seasoned subspe-
cialist. In the Journal, we have recently implemented
editorial decisions simply because they serve these
varied communities. In every issue, we have a
Fellows-in-Training/Early Career Page, where we give
young cardiovascular specialists a prominent forum
to discuss the challenges and opportunities associ-
ated with being at an early stage of one’s career. Each
issue is accompanied by an audio recording, available
as a downloadable podcast, to describe the thrust
of the overall issue, in addition to providing my
perspective on each paper. These decisions were
made with the goal of serving our readers, even
though they will not move Impact Factor.
As physicians, we all need to continue to learn and
change based on high-quality data, which are pub-
lished in prestigious journals. We, as the editors
of these journals, cannot become consumed with
competing with each other, but must instead propelthe quality of medical publishing together. This
brings to mind an old quote by former U.S. President
Harry Truman: “it is amazing what you can accom-
plish if you do not care who gets the credit” (3). We
have an important responsibility as the editors of
these journals, and we must serve the best interest of
our readers, not get consumed with earning accolades
nor taking credit.
Please do not mistake my message. I am honored to
be serving as the Editor-in-Chief of JACC, but it is
truly this concept of service that drives many of
my decisions for the Journal. However, successful
journals require clearly deﬁned goals. At JACC, our
goal is to publish comprehensive, clinical papers of the
highest translational value. This does not mean we do
not publish basic science papers, but we only consider
basic science papers with a clear translational path to
clinical application. As editors, we need to establish
clear goals among our board members, in order to
collectively and consistently deliver high quality to
our readers. I will continue to use my intellect and
conscience to drive decisions at the Journal—and
I encourage our associate editors to do the same.
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